Synthetic Vaccines

Vaxxilon was founded to develop synthetic carbohydrate vaccines. These vaccines are comprised of oligosaccharides (small fragments of naturally occurring carbohydrates) attached to either to a carrier protein to create a semi-synthetic or the novel immune stimulator, alpha galactosylceramide, to create a fully synthetic vaccine.